Update: 22.10.2024
Last week: 41 week 2024 (07.10.2024 - 13.10.2024)
Last full month: September 2024
| Time period | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| AMBENE BIO | |||||||||
| WoW | 10 623 | 6.9% | 13.9% | 0.1 | 17 230 780 | 2.3% | 8.7% | -0.2 | 5.7% |
| MoM | 36 980 | 4.9% | 13.4% | -0.1 | 67 216 861 | 2.1% | 9.2% | -0.3 | 5.8% |
| YTD | 311 607 | 23.4% | 12.0% | 3.1 | 640 446 211 | 35.0% | 9.4% | 2 | -9.0% |
| MAT | 399 935 | 25.7% | 11.5% | 2.7 | 822 892 193 | 38.9% | 9.2% | 1.8 | -3.6% |
| BRAINMAX | |||||||||
| WoW | 2 562 | 3.7% | 100.0% | 0 | 8 790 651 | 3.6% | 100.0% | 0 | 3.7% |
| MoM | 7 570 | 10.4% | 100.0% | 0 | 26 517 643 | 8.2% | 100.0% | 0 | 10.4% |
| YTD | 54 261 | 64.6% | 100.0% | 0 | 190 965 402 | 69.7% | 100.0% | 0 | 64.6% |
| MAT | 67 939 | 72.3% | 100.0% | 0 | 239 431 162 | 79.8% | 100.0% | 0 | 72.3% |
| GOLDLINE PLUS | |||||||||
| WoW | 14 512 | 0.5% | 45.9% | -0.4 | 45 123 106 | 0.7% | 37.4% | -0.5 | 1.2% |
| MoM | 61 246 | -7.0% | 45.9% | 0.3 | 190 178 090 | -6.9% | 37.7% | 0.1 | -7.6% |
| YTD | 670 730 | -5.1% | 45.1% | 0.4 | 2 107 224 124 | -3.0% | 36.9% | -2.8 | -6.0% |
| MAT | 833 268 | -1.6% | 45.3% | 0.5 | 2 627 070 535 | 2.0% | 37.4% | -2.4 | -2.6% |
| MIGRENIUM | |||||||||
| WoW | 8 900 | -5.7% | 0.4% | 0 | 3 031 269 | -5.6% | 0.5% | -0.1 | 4.0% |
| MoM | 41 151 | -21.4% | 0.4% | -0.1 | 13 849 561 | -20.6% | 0.6% | -0.1 | -2.8% |
| YTD | 467 873 | -10.3% | 0.5% | -0.1 | 147 236 827 | 52.7% | 0.7% | 0.2 | 6.6% |
| MAT | 587 748 | -10.0% | 0.5% | -0.1 | 173 474 390 | 44.5% | 0.6% | 0.1 | 10.2% |
| MODELAX-N | |||||||||
| WoW | 25 835 | -3.2% | 19.4% | -1.7 | 12 308 647 | -2.2% | 12.7% | -1.1 | 5.5% |
| MoM | 107 577 | 0.1% | 20.6% | 1.1 | 50 949 280 | 1.1% | 13.5% | 0.7 | -5.3% |
| YTD | 1 162 507 | 29.8% | 22.3% | 3.5 | 509 979 656 | 79.0% | 14.4% | 4 | 9.1% |
| MAT | 1 434 581 | 38.6% | 21.4% | 3.8 | 607 930 356 | 83.1% | 13.5% | 3.7 | 13.7% |
| REDUXIN | |||||||||
| WoW | 10 343 | 3.8% | 32.7% | 0.8 | 54 125 163 | 4.7% | 44.9% | 1.1 | 1.2% |
| MoM | 42 769 | -9.5% | 32.1% | -0.7 | 220 075 387 | -8.9% | 43.7% | -0.8 | -7.6% |
| YTD | 487 736 | -7.5% | 32.8% | -0.5 | 2 592 724 823 | 11.9% | 45.4% | 3.1 | -6.0% |
| MAT | 598 176 | -5.1% | 32.5% | -0.9 | 3 148 612 821 | 15.5% | 44.8% | 2.7 | -2.6% |
| REDUXIN FORTE | |||||||||
| WoW | 3 038 | -5.7% | 9.6% | -0.7 | 12 846 793 | -4.9% | 10.7% | -0.8 | 1.2% |
| MoM | 13 776 | -1.3% | 10.3% | 0.7 | 58 932 380 | 0.6% | 11.7% | 0.9 | -7.6% |
| YTD | 134 532 | 1.2% | 9.1% | 0.6 | 579 526 116 | 12.5% | 10.2% | 0.7 | -6.0% |
| MAT | 167 582 | 6.0% | 9.1% | 0.7 | 718 087 046 | 17.6% | 10.2% | 0.8 | -2.6% |
| SALVISAR | |||||||||
| WoW | 12 532 | 15.5% | 1.6% | 0.2 | 5 460 669 | 17.3% | 1.4% | 0.2 | 3.5% |
| MoM | 47 722 | 21.0% | 1.5% | 0.3 | 20 388 247 | 20.6% | 1.3% | 0.2 | -2.4% |
| YTD | 415 464 | 5.5% | 1.4% | 0.1 | 171 179 658 | 32.3% | 1.2% | 0.2 | -2.3% |
| MAT | 520 115 | -4.3% | 1.3% | -0.1 | 205 550 491 | 13.3% | 1.2% | 0 | 1.5% |
| Brand | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| AMBENE BIO | 311 607 | 23.4% | 12.0% | 3.1 | 640 446 211 | 35.0% | 9.4% | 2 | -9.0% |
| BRAINMAX | 54 261 | 64.6% | 100.0% | 0 | 190 965 402 | 69.7% | 100.0% | 0 | 64.6% |
| GOLDLINE PLUS | 670 730 | -5.1% | 45.1% | 0.4 | 2 107 224 124 | -3.0% | 36.9% | -2.8 | -6.0% |
| MIGRENIUM | 467 873 | -10.3% | 0.5% | -0.1 | 147 236 827 | 52.7% | 0.7% | 0.2 | 6.6% |
| MODELAX-N | 1 162 507 | 29.8% | 22.3% | 3.5 | 509 979 656 | 79.0% | 14.4% | 4 | 9.1% |
| REDUXIN CAPS | 487 736 | -7.5% | 32.8% | -0.5 | 2 592 724 823 | 11.9% | 45.4% | 3.1 | -6.0% |
| REDUXIN FORTE | 134 532 | 1.2% | 9.1% | 0.6 | 579 526 116 | 12.5% | 10.2% | 0.7 | -6.0% |
| SALVISAR | 415 464 | 5.5% | 1.4% | 0.1 | 171 179 658 | 32.3% | 1.2% | 0.2 | -2.3% |
| Brand | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| AMBENE BIO | 399 935 | 25.7% | 11.5% | 2.7 | 822 892 193 | 38.9% | 9.2% | 1.8 | -3.6% |
| BRAINMAX | 67 939 | 72.3% | 100.0% | 0 | 239 431 162 | 79.8% | 100.0% | 0 | 72.3% |
| GOLDLINE PLUS | 833 268 | -1.6% | 45.3% | 0.5 | 2 627 070 535 | 2.0% | 37.4% | -2.4 | -2.6% |
| MIGRENIUM | 587 748 | -10.0% | 0.5% | -0.1 | 173 474 390 | 44.5% | 0.6% | 0.1 | 10.2% |
| MODELAX-N | 1 434 581 | 38.6% | 21.4% | 3.8 | 607 930 356 | 83.1% | 13.5% | 3.7 | 13.7% |
| REDUXIN CAPS | 598 176 | -5.1% | 32.5% | -0.9 | 3 148 612 821 | 15.5% | 44.8% | 2.7 | -2.6% |
| REDUXIN FORTE | 167 582 | 6.0% | 9.1% | 0.7 | 718 087 046 | 17.6% | 10.2% | 0.8 | -2.6% |
| SALVISAR | 520 115 | -4.3% | 1.3% | -0.1 | 205 550 491 | 13.3% | 1.2% | 0 | 1.5% |
| Brand | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| AMBENE BIO | 10 623 | 6.9% | 13.9% | 0.1 | 17 230 780 | 2.3% | 8.7% | -0.2 | 5.7% |
| BRAINMAX | 2 562 | 3.7% | 100.0% | 0 | 8 790 651 | 3.6% | 100.0% | 0 | 3.7% |
| GOLDLINE PLUS | 14 512 | 0.5% | 45.9% | -0.4 | 45 123 106 | 0.7% | 37.4% | -0.5 | 1.2% |
| MIGRENIUM | 8 900 | -5.7% | 0.4% | 0 | 3 031 269 | -5.6% | 0.5% | -0.1 | 4.0% |
| MODELAX-N | 25 835 | -3.2% | 19.4% | -1.7 | 12 308 647 | -2.2% | 12.7% | -1.1 | 5.5% |
| REDUXIN CAPS | 10 343 | 3.8% | 32.7% | 0.8 | 54 125 163 | 4.7% | 44.9% | 1.1 | 1.2% |
| REDUXIN FORTE | 3 038 | -5.7% | 9.6% | -0.7 | 12 846 793 | -4.9% | 10.7% | -0.8 | 1.2% |
| SALVISAR | 12 532 | 15.5% | 1.6% | 0.2 | 5 460 669 | 17.3% | 1.4% | 0.2 | 3.5% |
| Brand | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| AMBENE BIO | 36 980 | 4.9% | 13.4% | -0.1 | 67 216 861 | 2.1% | 9.2% | -0.3 | 5.8% |
| BRAINMAX | 7 570 | 10.4% | 100.0% | 0 | 26 517 643 | 8.2% | 100.0% | 0 | 10.4% |
| GOLDLINE PLUS | 61 246 | -7.0% | 45.9% | 0.3 | 190 178 090 | -6.9% | 37.7% | 0.1 | -7.6% |
| MIGRENIUM | 41 151 | -21.4% | 0.4% | -0.1 | 13 849 561 | -20.6% | 0.6% | -0.1 | -2.8% |
| MODELAX-N | 107 577 | 0.1% | 20.6% | 1.1 | 50 949 280 | 1.1% | 13.5% | 0.7 | -5.3% |
| REDUXIN CAPS | 42 769 | -9.5% | 32.1% | -0.7 | 220 075 387 | -8.9% | 43.7% | -0.8 | -7.6% |
| REDUXIN FORTE | 13 776 | -1.3% | 10.3% | 0.7 | 58 932 380 | 0.6% | 11.7% | 0.9 | -7.6% |
| SALVISAR | 47 722 | 21.0% | 1.5% | 0.3 | 20 388 247 | 20.6% | 1.3% | 0.2 | -2.4% |
ОБОЗНАЧЕНИЯ
WoW - Week Over Week - показатели для сравнения результатов текущей и предыдущей недели
MoM - Month Over Month - показатели для сравнения результатов последнего полного месяца и предыдущего полного месяца
YTD - Year to Date - показатели для сравнения результатов за период времени, начинающийся с первого дня текущего календарного года до текущей даты с результатами за сопоставимый период прошлого года
MAT - Moving Annual Total - показатели для сравнения результатов за период 12 месяцев, с датой окончания на последней доступной неделе, с результатами за сопоставимый период прошлого года
MS - Market Share - Доля рынка = (Продажи бренда / Продажи категории)*100%
Change, % = (Продажи бренда за последний период / Продажи бренда за предыдущий период - 1)*100%
Change, p.p. = Доля бренда на рынке за последний период - Доля бренда на рынке за предыдущий период (выражается в процентных пунктах)
Cat. Volume Change, % = (Продажи категории в упаковках за последний период / Продажи категории в упаковках за предыдущий период - 1)*100%
Каждая категория собрана специально для каждого бренда и включает в себя бренд и его конкурентов
Список конкурентов можно найти в разделе “MS of competitors” в блоке каждого бренда
ABBREVIATIONS
WoW - Week Over Week - indicators for comparing the results of the current and previous week
MoM - Month Over Month - indicators for comparing the results of the* last full month* and previous full month
YTD - Year to Date - indicators for comparing the results of the period of time beginning the first day of the current calendar year up to the current date with the results of the comparable period last year
MAT - Moving Annual Total - indicators for comparing the results of the period, being 12 month period ending on the last week with the results of the comparable period last year
MS - Market Share - (Brand Sales / Category Sales)*100%
Change, % = (Brand Sales of the last period / Brand Sales of the previous period - 1)*100%
Change, p.p. = Brand Market Share of the last period - Brand Market Share of the previous period (expressed in percentage points)
Cat. Volume Change, % = (Category Sales in packs of the last period / Category Sales in packs of the previous period - 1)*100%
Each category is created specifically for each brand and includes the brand and its competitors
The list of competitors can be found in the subsection “MS of competitors” in sections for each brand
## [1] "MODELAX-N"
## [1] "MODELAX-N SOL RECTAL USE 5 ML #2"
## [1] "MODELAX-N SOL RECTAL USE 5 ML #4"
## [1] "MODELAX-N SOL RECTAL USE 5 ML #8"
## [1] "MODELAX-N"
## [1] "MODELAX-N SOL RECTAL USE 5 ML #2"
## [1] "MODELAX-N SOL RECTAL USE 5 ML #4"
## [1] "MODELAX-N SOL RECTAL USE 5 ML #8"
## [1] "AMBENE BIO"
## [1] "AMBENE BIO SOL FOR INJ 1 ML #10"
## [1] "AMBENE BIO SOL FOR INJ 2 ML #5"
## [1] "AMBENE BIO"
## [1] "AMBENE BIO SOL FOR INJ 1 ML #10"
## [1] "AMBENE BIO SOL FOR INJ 2 ML #5"
## [1] "MIGRENIUM"
## [1] "MIGRENIUM COATED TABLETS 65 MG+500 MG #20"
## [1] "MIGRENIUM"
## [1] "MIGRENIUM COATED TABLETS 65 MG+500 MG #20"
## [1] "SALVISAR"
## [1] "SALVISAR UNGUENT FOR EXT USE 100 G #1"
## [1] "SALVISAR UNGUENT FOR EXT USE 25 G #1"
## [1] "SALVISAR UNGUENT FOR EXT USE 25 G #2"
## [1] "SALVISAR UNGUENT FOR EXT USE 50 G #1"
## [1] "SALVISAR"
## [1] "SALVISAR UNGUENT FOR EXT USE 100 G #1"
## [1] "SALVISAR UNGUENT FOR EXT USE 25 G #1"
## [1] "SALVISAR UNGUENT FOR EXT USE 25 G #2"
## [1] "SALVISAR UNGUENT FOR EXT USE 50 G #1"
## [1] "REDUXIN CAPS"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #10"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #30"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #60"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #60"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #60"
## [1] "REDUXIN CAPS 15 MG+153,5 MG #30"
## [1] "REDUXIN CAPS 15 MG+153,5 MG #60"
## [1] "REDUXIN CAPS 15 MG+153,5 MG #90"
## [1] "REDUXIN CAPS"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #10"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #30"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #60"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #90"
## [1] "REDUXIN CAPS 15 MG+153,5 MG #10"
## [1] "REDUXIN CAPS 15 MG+153,5 MG #30"
## [1] "REDUXIN CAPS 15 MG+153,5 MG #60"
## [1] "REDUXIN CAPS 15 MG+153,5 MG #90"
## [1] "REDUXIN FORTE"
## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #30"
## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #60"
## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #90"
## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #90"
## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #90"
## [1] "REDUXIN FORTE TABS 850 MG + 10 MG #90"
## [1] "REDUXIN FORTE"
## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #30"
## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #60"
## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #90"
## [1] "REDUXIN FORTE TABS 850 MG + 10 MG #30"
## [1] "REDUXIN FORTE TABS 850 MG + 10 MG #60"
## [1] "REDUXIN FORTE TABS 850 MG + 10 MG #90"
## [1] "GOLDLINE PLUS"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #10"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #30"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #60"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #60"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #60"
## [1] "GOLDLINE PLUS CAPS 15 MG+153,5 MG #30"
## [1] "GOLDLINE PLUS CAPS 15 MG+153,5 MG #60"
## [1] "GOLDLINE PLUS CAPS 15 MG+153,5 MG #90"
## [1] "GOLDLINE PLUS"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #10"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #30"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #60"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #90"
## [1] "GOLDLINE PLUS CAPS 15 MG+153,5 MG #10"
## [1] "GOLDLINE PLUS CAPS 15 MG+153,5 MG #30"
## [1] "GOLDLINE PLUS CAPS 15 MG+153,5 MG #60"
## [1] "GOLDLINE PLUS CAPS 15 MG+153,5 MG #90"
## [1] "BRAINMAX"
## [1] "BRAINMAX CAPS 250 MG+250 MG #20"
## [1] "BRAINMAX CAPS 250 MG+250 MG #40"
## [1] "BRAINMAX CAPS 250 MG+250 MG #60"
## [1] "BRAINMAX SOL FOR INTRAVEN&INTRAMUSC INJ 100 MG/ML+100 MG/ML 2,5 ML #10"
## [1] "BRAINMAX SOL FOR INTRAVEN&INTRAMUSC INJ 100 MG/ML+100 MG/ML 5 ML #10"
## [1] "BRAINMAX"
## [1] "BRAINMAX CAPS 250 MG+250 MG #20"
## [1] "BRAINMAX CAPS 250 MG+250 MG #40"
## [1] "BRAINMAX CAPS 250 MG+250 MG #60"
## [1] "BRAINMAX SOL FOR INTRAVEN&INTRAMUSC INJ 100 MG/ML+100 MG/ML 2,5 ML #10"
## [1] "BRAINMAX SOL FOR INTRAVEN&INTRAMUSC INJ 100 MG/ML+100 MG/ML 5 ML #10"
[RUS] ОБОЗНАЧЕНИЯ
WoW - Week Over Week - показатели для сравнения результатов текущей и предыдущей недели
MoM - Month Over Month - показатели для сравнения результатов последнего полного месяца и предыдущего полного месяца
YTD - Year to Date - показатели для сравнения результатов за период времени, начинающийся с первого дня текущего календарного года до текущей даты с результатами за сопоставимый период прошлого года
MAT - Moving Annual Total - показатели для сравнения результатов за период 12 месяцев, с датой окончания на последней доступной неделе, с результатами за сопоставимый период прошлого года
MS - Market Share - Доля рынка = (Продажи бренда / Продажи категории)*100%
Change, % = (Продажи бренда за последний период / Продажи бренда за предыдущий период - 1)*100%
Change, p.p. = Доля бренда на рынке за последний период - Доля бренда на рынке за предыдущий период (выражается в процентных пунктах)
Cat. Volume Change, % = (Продажи категории в упаковках за последний период / Продажи категории в упаковках за предыдущий период - 1)*100%
Каждая категория собрана специально для каждого бренда и включает в себя бренд и его конкурентов
Список конкурентов можно найти в разделе “MS of competitors” в блоке каждого бренда
[ENG] ABBREVIATIONS
WoW - Week Over Week - indicators for comparing the results of the current and previous week
MoM - Month Over Month - indicators for comparing the results of the last full month and previous full month
YTD - Year to Date - indicators for comparing the results of the period of time beginning the first day of the current calendar year up to the current date with the results of the comparable period last year
MAT - Moving Annual Total - indicators for comparing the results of the period, being 12 month period ending on the last week with the results of the comparable period last year
MS - Market Share - (Brand Sales / Category Sales)*100%
Change, % = (Brand Sales of the last period / Brand Sales of the previous period - 1)*100%
Change, p.p. = Brand Market Share of the last period - Brand Market Share of the previous period (expressed in percentage points)
Cat. Volume Change, % = (Category Sales in packs of the last period / Category Sales in packs of the previous period - 1)*100%
Each category is created specifically for each brand and includes the brand and its competitors
The list of competitors can be found in the subsection “MS of competitors” in sections for each brand
DATA SOURCES:
DSM: Sales
Palomars: TRPs